FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

4 results

dabigatran
(DABIGATRAN ETEXILATE)
AvKARE
Usage: Dabigatran etexilate is indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism, preventing recurrence of these conditions, and for prophylaxis after hip replacement surgery in adult patients.
dabigatran etexilate
(Dabigatran Etexilate)
Alembic Pharmaceuticals Limited
Usage: Dabigatran etexilate is indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism after parenteral anticoagulant use, preventing recurrence of these conditions, and providing prophylaxis following hip replacement surgery in adults.
pradaxa
(dabigatran etexilate mesylate)
Boehringer Ingelheim Pharmaceuticals Inc.
Usage: PRADAXA Capsules are indicated for reducing the risk of stroke and systemic embolism in adults with non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism in adults, prophylaxis post-hip replacement surgery, and treating and preventing venous thromboembolic events in pediatric patients aged 8 to less than 18 years.
xarelto
(rivaroxaban)
Janssen Pharmaceuticals, Inc.
Usage: XARELTO is indicated for reducing the risk of stroke in nonvalvular atrial fibrillation, treating deep vein thrombosis (DVT) and pulmonary embolism (PE), preventing DVT after hip or knee replacement, and reducing major cardiovascular events in coronary artery disease. It's also used in pediatric patients for VTE treatment and prevention.

Medications for Recurrent Deep Vein Thrombosis

dabigatran

dabigatran etexilate

pradaxa

xarelto